64. Clin Transl Oncol. 2018 Mar 6. doi: 10.1007/s12094-018-1852-1. [Epub ahead ofprint]Long-term crude probabilities of death among breast cancer patients by age andstage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).Clèries R(1)(2), Ameijide A(3), Buxó M(4), Martínez JM(5), Marcos-GrageraR(6)(7)(8), Vilardell ML(6)(7), Carulla M(3), Yasui Y(9), Vilardell M(10),Espinàs JA(11), Borràs JM(11)(12), Galceran J(3)(13), Izquierdo À(6)(7)(14).Author information: (1)Pla Director d'Oncologia (GENCAT), IDIBELL, Hospital Duran i Reynals, Gran Via199-203 1ª planta, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.r.cleries@iconcologia.net.(2)Departament de Ciències Clíniques, Universitat de Barcelona, Campus deBellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.r.cleries@iconcologia.net.(3)Registre de Càncer de Tarragona, Fundació Lliga per a la Investigació iPrevenció del Càncer (FUNCA)-IISPV, Reus, Tarragona, Spain.(4)Institut d'Investigació Biomèdica de Girona, IDIBGI, C/Dr.Castany s/n, EdificiM2, Parc Hospitalari Martí i Julià, 17190, Salt, Spain.(5)MC MUTUAL, Departamento de Investigación y Análisis de Prestaciones,C/Provenza, 321, 08037, Barcelona, Spain.(6)Unitat d'Epidemiologia i Registre del Càncer de Girona (UERGG), Institutd'Investigació Biomèdica Girona Josep Trueta (IDIBGI), Girona, Spain.(7)Institut Català d'Oncologia (ICO), Girona, Spain.(8)Departament d'Infermeria, Universitat de Girona (UdG), Girona, Spain.(9)Department of Epidemiology and Cancer Control, St. Jude Children's ResearchHospital, Memphis, TN, 38105, USA.(10)Sección de Estadística del Departamento de Genética, Microbiología yEstadística de la Facultad de Biología, Universidad de Barcelona, 08028,Barcelona, Spain.(11)Pla Director d'Oncologia (GENCAT), IDIBELL, Hospital Duran i Reynals, GranVia 199-203 1ª planta, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.(12)Departament de Ciències Clíniques, Universitat de Barcelona, Campus deBellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.(13)Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Reus,Tarragona, Spain.(14)Departament d'Oncología Médica, Institut Català d'Oncologia, HospitalUniversitari Doctor Josep Trueta, Girona, Spain.BACKGROUND: We provide population-based long-term survival indicators of breastcancer patients by quantifying the observed survival, and the probabilities ofdeath due to breast cancer and to other causes by age and tumor stage atdiagnosis.METHODS: We included a total of 10,195 female patients diagnosed before 85 years with invasive primary breast cancer in Girona and Tarragona during the periods1985-1994 and 1995-2004 and followed-up until December 31st 2014. The survivalindicators were estimated at 5, 10, 15 and 20 years of follow-up comparingdiagnostic periods.RESULTS: Comparing diagnostic periods: I) the probability of death due to othercauses did not change; II) the 20-year survival for women diagnosed ≤ 49 yearsincreased 13% (1995-2004 = 68%; 1985-1994:55%), whereas their probability ofdeath due to breast cancer decreased at the same pace (1995-2004 = 29%;1985-1994 = 42%); III) at 10 years of follow-up, decreases in the probabilitiesof death due to breast cancer across age groups switched from 11 to 17% resultingin a risk of death reduction of 19% after adjusting by stage. During 1995-2004,the stage-specific 10-year probabilities of death due to breast cancer switchedfrom: 3-6% in stage I, 18-20% in stage II, 34-46% in stage III and surpassed 70% in stage IV beyond 5 years after diagnosis.CONCLUSIONS: In our study, women diagnosed with breast cancer had higherlong-term probability to die from breast cancer than from other causes. Theimprovements in treatment and the lead-time bias in detecting cancer in an early stage resulted in a reduction of 19% in the risk of death between diagnosticperiods.DOI: 10.1007/s12094-018-1852-1 PMID: 29511947 